JERUSALEM, May 13, 2014 /PRNewswire via COMTEX/ -- JERUSALEM, May 13, 2014 /PRNewswire/ --
Oramed Pharmaceuticals Inc. (nasdaqcm:ORMP) ( http://www.oramed.com ), a clinical-stage pharmaceutical company focused on the development of oral drug delivery systems, announced today that a poster on the Company’s orally ingestible insulin capsule, ORMD-0801, will be presented at the Yale Diabetes Symposium on Wednesday, May 14, 2014.
Help employers find you! Check out all the jobs and post your resume.
